FDA Inspection
Waylis TherapeuticsFDA Inspection 1303428 - Waylis Therapeutics - February 12, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Waylis Therapeutics, with an inspection on February 12, 2026, issued by the New Jersey District Office, covering human drugs.
Open in Dashboard
ID · 9556879f-5f81-4433-881b-59a74b649726
Violation Codes1
21 CFR 314.80(b)
Full citation text and observation details available on the Dashboard.